Article Listing - UK's NICE draft guidance recommends Bristol-Myers Orencia for RA

INTERFERON ALFA-N3 AND AIDS

6 April 1992

Researchers at the Walter Reed Army Institute of Research and at Interferon Sciences have commenced Phase I trials with the...

GERMAN POLICY UNDER FIRE

6 April 1992

German Health Minister Gerda Hasselfeldt has accused the leading German doctors' organization, the Hartmannbund, of political agitation, after it held...

SANOFI 1991 NET INCOME UP 12.1%

6 April 1992

For France's Elf Sanofi, earnings progressed satisfactorily in 1991 despite the adverse operating environment (the world economic situation including the...

WORLD MARKET FOR BIO-DRUGS

6 April 1992

Biopharmaceuticals will be the single fastest-growing segment of the total pharmaceutical market worldwide in the 1990s, with average annual growth...

PFIZER'S DIFLUCAN

6 April 1992

Prophylactic administration of Pfizer's Diflucan (fluconazole) to recipients of autologous bone marrow transplants reduces the incidence of both systemic and...

ALLELIX BIOPHARMA: DOUGLAS FROOM

6 April 1992

Douglas Froom has been appointed as vice president for business development at Allelelix Biopharmaceuticals Inc, of Canada.

GENZYME AND CYSTIC FIBROSIS

6 April 1992

Genzyme is to exercise its option to buy rights to Neozyme's cystic fibrosis protein replacement therapeutic program, under the terms...

GERMAN PRICE SUPPORT EXTENDED

6 April 1992

The leading German health insurance funds have announced further fixed-price support arrangements for a new range of drug products, and...

ASPIRIN HELPS BAYER IN ITALY

6 April 1992

Favorable trends in drugs business and especially good sales of standard products such as aspirin are reported to have helped...

ROBERTS PHARMA ACQUIRES NCRC

6 April 1992

The US concern Roberts Pharma-ceutical has reached a definitive agreement to acquire the National Clinical Research Centers in the USA...

Showing 94451-94460 of 95376 articles